+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bone Growth Stimulators Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026

  • ID: 5031477
  • Report
  • March 2020
  • Region: Global
  • 238 pages
  • Allied Analytics LLP
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Arthrex Inc.
  • Isto Biologics
  • Medtronic Plc
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE
The global bone growth stimulators market was valued at $1,242 million in 2018, and is estimated to reach at $1,869 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.

Bone growth stimulators are used for bone growth, which also aid in broken bone healing process. Bone growth stimulators help in production of new bone cells and work in case of all fractures. In addition, it is used for healing of long leg bones such as tibia and in surgical procedures such as spinal fusions, which are difficult to heal. Bone growth stimulators include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.

a rise in the number of trauma and accident cases, increase in The prevalence of arthritis, surge in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in geriatric population, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins are some factors that fuel the growth of the bone growth stimulators market. In addition, rise in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders are also expected to drive the market during the forecast period. Moreover, bone growth stimulation products offer more benefits compared to traditional surgical therapies such as cost-effective and safe alternative mode to treat orthopedic diseases and bone fracture treatment. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.

The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS
  • The study provides an in-depth analysis of the global bone growth stimulators market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
  • Comprehensive quantitative analysis of the industry from 2018 to 2026 is provided to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the key segments of the industry helps to understand the application and products of bone growth stimulators used across the globe.
  • Key market players and their strategies have been analyzed to understand the competitive outlook of the market.
KEY MARKET SEGMENTS

By Product
  • Bone Growth Stimulation Devices
  • Bone Morphogenetic Proteins
  • Platelet-Rich Plasma
By Application
  • Spinal Fusion Surgeries
  • Delayed Union & Nonunion Bone Fractures
  • Oral & Maxillofacial Surgeries
  • Others
By Distribution Channel
  • Hospitals & Clinics
  • Home Care
  • Others
By Region
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
  • Arthrex, Inc.
  • Essex Woodlands Healthcare Partners (Bioventus LLC)
  • Colfax Corporation (DJO Global, Inc)
  • Isto Biologics
  • Johnson & Johnson (Depuy Synthes)
  • Medtronic PLC
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings, Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request.)
  • ITO Physiotherapy & Rehabilitation
  • Orchid Medical
  • Ossatec Benelux Ltd.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Arthrex Inc.
  • Isto Biologics
  • Medtronic Plc
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Market player positioning, 2018
3.3. Porter’s five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in demand for non-invasive and safer surgical treatments
3.4.1.2. Increase in number of patients demanding bone growth stimulators
3.4.1.3. Increase in government expenditure on healthcare
3.4.2. Restraint
3.4.2.1. Stringent approval process of bone growth stimulators
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
3.4.4. Impact analysis

CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Bone growth stimulation devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Bone Morphogenetic Proteins
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Platelet-rich plasma
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Spinal Fusion Surgeries
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Delayed Union & Nonunion Bone Fractures
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Oral & Maxillofacial Surgeries
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Others
5.5.1. Market size and forecast
5.5.2. Market analysis, by country

CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Home Care
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Others
6.4.1. Market size and forecast
6.4.2. Market analysis, by country

CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U. S.
7.2.2.1.1. U. S. bone growth stimulators market, by product
7.2.2.1.2. U. S. bone growth stimulators market, by application
7.2.2.1.3. U. S. bone growth stimulators market, by distribution channel
7.2.2.2. Canada
7.2.2.2.1. Canada bone growth stimulators market, by product
7.2.2.2.2. Canada bone growth stimulators market, by application
7.2.2.2.3. Canada bone growth stimulators market, by distribution channel
7.2.2.3. Mexico
7.2.2.3.1. Mexico bone growth stimulators market, by product
7.2.2.3.2. Mexico bone growth stimulators market, by application
7.2.2.3.3. Mexico bone growth stimulators market, by distribution channel
7.2.3. North America market size and forecast, by product
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by distribution channel
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany bone growth stimulators market, by product
7.3.2.1.2. Germany bone growth stimulators market, by application
7.3.2.1.3. Germany bone growth stimulators market, by distribution channel
7.3.2.2. France
7.3.2.2.1. France bone growth stimulators market, by product
7.3.2.2.2. France bone growth stimulators market, by application
7.3.2.2.3. France bone growth stimulators market, by distribution channel
7.3.2.3. UK
7.3.2.3.1. UK bone growth stimulators market, by product
7.3.2.3.2. UK bone growth stimulators market, by application
7.3.2.3.3. UK bone growth stimulators market, by distribution channel
7.3.2.4. Italy
7.3.2.4.1. Italy bone growth stimulators market, by product
7.3.2.4.2. Italy bone growth stimulators market, by application
7.3.2.4.3. Italy bone growth stimulators market, by distribution channel
7.3.2.5. Spain
7.3.2.5.1. Spain bone growth stimulators market, by product
7.3.2.5.2. Spain bone growth stimulators market, by application
7.3.2.5.3. Spain bone growth stimulators market, by distribution channel
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe bone growth stimulators market, by product
7.3.2.6.2. Rest of Europe bone growth stimulators market, by application
7.3.2.6.3. Rest of Europe bone growth stimulators market, by distribution channel
7.3.3. Europe market size and forecast, by product
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by distribution channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan bone growth stimulators market, by product
7.4.2.1.2. Japan bone growth stimulators market, by application
7.4.2.1.3. Japan bone growth stimulators market, by distribution channel
7.4.2.2. China
7.4.2.2.1. China bone growth stimulators market, by product
7.4.2.2.2. China bone growth stimulators market, by application
7.4.2.2.3. China bone growth stimulators market, by distribution channel
7.4.2.3. Australia
7.4.2.3.1. Australia bone growth stimulators market, by product
7.4.2.3.2. Australia bone growth stimulators market, by application
7.4.2.3.3. Australia bone growth stimulators market, by distribution channel
7.4.2.4. India
7.4.2.4.1. India bone growth stimulators market, by product
7.4.2.4.2. India bone growth stimulators market, by application
7.4.2.4.3. India bone growth stimulators market, by distribution channel
7.4.2.5. South Korea
7.4.2.5.1. South Korea bone growth stimulators market, by product
7.4.2.5.2. South Korea bone growth stimulators market, by application
7.4.2.5.3. South Korea bone growth stimulators market, by distribution channel
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific bone growth stimulators market, by product
7.4.2.6.2. Rest of Asia-Pacific bone growth stimulators market, by application
7.4.2.6.3. Rest of Asia-Pacific bone growth stimulators market, by distribution channel
7.4.3. Asia-Pacific market size and forecast, by product
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by distribution channel
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil bone growth stimulators market, by product
7.5.2.1.2. Brazil bone growth stimulators market, by application
7.5.2.1.3. Brazil bone growth stimulators market, by distribution channel
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia bone growth stimulators market, by product
7.5.2.2.2. Saudi Arabia bone growth stimulators market, by application
7.5.2.2.3. Saudi Arabia bone growth stimulators market, by distribution channel
7.5.2.3. South Africa
7.5.2.3.1. South Africa bone growth stimulators market, by product
7.5.2.3.2. South Africa bone growth stimulators market, by application
7.5.2.3.3. South Africa bone growth stimulators market, by distribution channel
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA bone growth stimulators market, by product
7.5.2.4.2. Rest of LAMEA bone growth stimulators market, by application
7.5.2.4.3. Rest of LAMEA bone growth stimulators market, by distribution channel
7.5.3. LAMEA market size and forecast, by product
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by distribution channel

CHAPTER 8: COMPANY PROFILES
8.1. Arthrex, Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.2. Essex Woodlands Healthcare Partners (Bioventus LLC)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.1. Key strategic moves and developments
8.3. Colfax Corporation (DJO Global, Inc)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Isto Biologics
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. JOHNSON & JOHNSON (DEPUY SYNTHES)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. MEDTRONIC PLC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. Orthofix Medical Inc.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. STRYKER CORPORATION
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Terumo Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.10. ZIMMER BIOMET HOLDINGS, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
Note: Product cover images may vary from those shown
3 of 5

FEATURED COMPANIES

  • Arthrex Inc.
  • Isto Biologics
  • Medtronic Plc
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • MORE
According to this report titled, 'Bone Growth Stimulators Market by Product, Application, and Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2019-2026' the global bone growth stimulators market size was valued at $1,242 million in 2018, and is projected to reach $1,869 million by 2026, growing at a CAGR of 5.2% from 2019 to 2026.

Bone growth stimulators are used to aid natural healing process of bones. They are also known as osteogenesis stimulators, which offer pain-free ultrasound or electrical stimulation. Bone growth stimulators work by releasing either a low-level pulsed electromagnetic field or pulsed ultrasonic energy. The cost incurred in the application of minimally invasive bone growth stimulators is less as compared to traditional bone surgical treatment methods. There are different bone growth stimulator products available in the market, which include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.

The bone growth stimulators market is expected to experience a significant growth during the forecast period, owing to rise in incidence of fractured and accidents, rise in geriatric population, increase in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in demand for platelet-rich plasma and bone morphogenetic proteins, availability of cost effective bone growth stimulation devices, and surge in patient awareness toward bone growth stimulators. In addition, increase in The prevalence of arthritis, diabetes, and other medical conditions such as obesity, vascular disease, and renal disorders; and procedural benefits provided by bone growth stimulation devices in bone fracture treatment and orthopedic diseases boost the market growth. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.

By product, the bone growth stimulation devices is the major revenue contributor, and is projected to grow significantly during the forecast period The key factors that drive the market growth are rise in demand for bone growth stimulation devices, rise in geriatric population, increase in incidence of spinal deformities, technological advancements, development in bone growth stimulation devices, and a rise in the number of bone and joint problems.

On the basis of application, the spinal fusion surgeries segment accounted for the majority of the market share in 2018, owing to rise in incidences of spinal disorders, adoption rate of minimally invasive spinal surgeries, rise in technological advancements in spinal surgery, increase in incidence of obesity & degenerative spinal conditions, and an increase in patient preference toward spinal fusion surgery procedures across the globe.

According to Onkar Sumant, Manager, Healthcare, “growth of the bone growth stimulators market is attributed to increase in demand for bone growth stimulator devices. Furthermore, a rise in the adoption of minimally invasive & non-invasive surgical treatments and surge in geriatric population across the globe are other factors that contribute to the growth of the market.”

KEY FINDINGS OF THE STUDY
  • On the basis of product, the bone growth stimulation devices segment held more than 51.21% share in the global market in 2018.
  • On the basis of application, the spinal fusion surgeries segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.
  • According to distribution channel, the hospitals & clinics segment exhibits fastest growth and is expected to grow at a CAGR of 5.6% from 2019 to 2026.
  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.0% during the forecast period.
North America accounted for approximately 53.22% of the global bone growth stimulators market share in 2018 and is expected to remain dominant throughout the forecast period. This was attributed to the higher adoption of bone growth stimulator products, large presence of medical device companies, well developed healthcare infrastructure, and wide availability of bone growth stimulators drugs. On the other side, Asia-Pacific is expected to experience the highest growth rate during the forecast period, majorly due to improvements in healthcare infrastructure, a rise in the number of hospitals equipped with advanced medical facilities, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare.
Note: Product cover images may vary from those shown
4 of 5
  • Arthrex Inc.
  • Essex Woodlands Healthcare Partners (Bioventus LLC)
  • Colfax Corporation (DJO Global Inc.)
  • Isto Biologics
  • Johnson & Johnson (Depuy Synthes)
  • Medtronic Plc
  • Orthofix Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Zimmer Biomet Holdings Inc
Note: Product cover images may vary from those shown
5 of 5

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll